Advertisement

Topics

Drug Pricing Policy Show Moves Into Next Act WIth Biopharmas' Suit Against DTC Ad Rule

14:28 EDT 14 Jun 2019 | SCRIP

Merck, Lilly, Amgen join advertisers in suit against HHS; rule helped Trump administration spotlight industry pricing practices but potential impact...

      

Related Stories

 

Original Article: Drug Pricing Policy Show Moves Into Next Act WIth Biopharmas' Suit Against DTC Ad Rule

NEXT ARTICLE

More From BioPortfolio on "Drug Pricing Policy Show Moves Into Next Act WIth Biopharmas' Suit Against DTC Ad Rule"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Lilly
Eli Lilly and Company was founded in 1876, and is now the 9th largest pharmaceutical company based an annual sales which were just under $20bn in 2009. Orginally from the USA, Lilly now operates in over 50 countries with just under 40,000 employees. Appr...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...